🔗 Share this article

Treasury head Reeves has announced she is planning "targeted steps to tackle cost of living pressures" in the upcoming Budget.

Speaking to the BBC, she stated that curbing price rises is a collective responsibility of both the government and the Bank of England.

The United Kingdom's price growth is expected to be the most elevated among the G7 industrialized countries this year and the following year.

Possible Energy Cost Interventions

Reports indicate the administration could take action to lower utility costs, for instance by slashing the present 5% level of value-added tax charged on energy supplies.

A further approach is to cut some of the policy costs presently included in household expenses.

Budgetary Limitations and Expert Expectations

The administration will obtain the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for such actions.

The expectation from most experts is that Reeves will have to introduce tax increases or budget cuts in order to fulfill her declared fiscal targets.

Earlier on Thursday, analysis indicated there was a twenty-two billion pound deficit for the chancellor to resolve, which is at the more modest range of forecasts.

"There's a shared responsibility between the Bank of England and the administration to bear down further on some of the sources of inflation," Reeves told the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.

Revenue Pledges and International Issues

While a great deal of the focus has been on probable tax rises, the chancellor said the most recent data from the fiscal watchdog had not altered her pledge to manifesto promises not to raise tax levels on earnings tax, VAT or National Insurance.

She blamed an "uncertain global environment" with increasing geopolitical and commercial tensions for the fiscal revenue measures, probably to be directed on those "with the broadest shoulders."

Global Economic Tensions

Referring to concerns about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security always are paramount."

Last week's statement by Chinese authorities to strengthen trade restrictions on critical minerals and other materials that are essential for high-technology manufacturing led American leader Donald Trump to suggest an additional 100% import tax on imports from the Asian country, raising the risk of an full-scale commercial conflict between the two global powers.

The American finance chief called the Chinese decision "commercial pressure" and "a international production power grab."

Asked about considering the US offer to join its battle with China, Reeves said she was "very concerned" by China's measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "bad for the global economy and causes further challenges."

"In my view there are areas where we must challenge China, but there are also valuable opportunities to export to China's economy, including banking sector and other sectors of the economy. We've got to maintain that balance appropriate."

The chancellor also confirmed she was collaborating with international partners "on our own critical minerals plan, so that we are more independent."

NHS Drug Pricing and Funding

The Chancellor also admitted that the price the National Health Service pays for pharmaceuticals could increase as a consequence of ongoing talks with the Trump administration and its drugs companies, in exchange for lower tariffs and funding.

Some of the world's largest drug companies have said in recent statements that they are either pausing or canceling operations in the UK, with some blaming the low prices they are getting.

Last month, the government science advisor said the price the health service spends on drugs would have to go up to prevent businesses and drug research funding departing from the United Kingdom.

The Chancellor told the BBC: "We have seen due to the payment system, that clinical trials, innovative medicines have not been available in the UK in the extent that they are in other continental states."

"Our aim is to make sure that people receiving care from the NHS are can access the best life-saving treatments in the globe. And so we are looking at these issues, and... aiming to attract additional funding into the UK."